Patents by Inventor Joel Buckley
Joel Buckley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240050535Abstract: The invention provides topical compositions and methods for using the compositions. The compositions can be used for the treatment of fibrotic or connective tissue disorders involving scarring, sub-dermal plaque accumulations, or fibrosis of muscle tissue. The disorders can be painlessly treated by the topical application of a composition described herein. One or more calcium channel blocker agents can serve as an active ingredient of the compositions, optionally in combination with, for example, one or more of emu oil and superoxide dismutase. The composition can further include pharmaceutically acceptable carriers that can facilitate the non-invasive transdermal delivery of the active(s) to subdermal sites.Type: ApplicationFiled: March 27, 2023Publication date: February 15, 2024Inventors: Jeffry Twidwell, Joel Buckley, Harold Hoium
-
Patent number: 11622997Abstract: The invention provides topical compositions and methods for using the compositions. The compositions can be used for the treatment of fibrotic or connective tissue disorders involving scarring, sub-dermal plaque accumulations, or fibrosis of muscle tissue. The disorders can be painlessly treated by the topical application of a composition described herein. One or more calcium channel blocker agents can serve as an active ingredient of the compositions, optionally in combination with, for example, one or more of emu oil and superoxide dismutase. The composition can further include pharmaceutically acceptable carriers that can facilitate the non-invasive transdermal delivery of the active(s) to subdermal sites.Type: GrantFiled: December 21, 2015Date of Patent: April 11, 2023Assignee: Hybrid Medical, Inc.Inventors: Jeffry Twidwell, Joel Buckley, Harold Hoium
-
Publication number: 20230082254Abstract: The invention provides topical compositions and methods for using the compositions. The compositions can be used for the treatment of fibrotic or connective tissue disorders involving scarring, sub-dermal plaque accumulations, or fibrosis of muscle tissue. The disorders can be painlessly treated by the topical application of a composition described herein. One or more calcium channel blocker agents can serve as an active ingredient of the compositions, optionally in combination with, for example, one or more of emu oil and superoxide dismutase. The composition can further include pharmaceutically acceptable carriers that can facilitate the non-invasive transdermal delivery of the active(s) to subdermal sites.Type: ApplicationFiled: August 19, 2022Publication date: March 16, 2023Inventors: Jeffry Twidwell, Joel Buckley, Harold Hoium
-
Patent number: 11446363Abstract: The invention provides topical compositions and methods for using the compositions. The compositions can be used for the treatment of fibrotic or connective tissue disorders involving scarring, sub-dermal plaque accumulations, or fibrosis of muscle tissue. The disorders can be painlessly treated by the topical application of a composition described herein. One or more calcium channel blocker agents can serve as an active ingredient of the compositions, optionally in combination with, for example, one or more of emu oil and superoxide dismutase. The composition can further include pharmaceutically acceptable carriers that can facilitate the non-invasive transdermal delivery of the active(s) to subdermal sites.Type: GrantFiled: October 28, 2019Date of Patent: September 20, 2022Assignee: Hybrid Medical, Inc.Inventors: Jeffry Twidwell, Joel Buckley, Harold Hoium
-
Publication number: 20200121764Abstract: The invention provides topical compositions and methods for using the compositions. The compositions can be used for the treatment of fibrotic or connective tissue disorders involving scarring, sub-dermal plaque accumulations, or fibrosis of muscle tissue. The disorders can be painlessly treated by the topical application of a composition described herein. One or more calcium channel blocker agents can serve as an active ingredient of the compositions, optionally in combination with, for example, one or more of emu oil and superoxide dismutase. The composition can further include pharmaceutically acceptable carriers that can facilitate the non-invasive transdermal delivery of the active(s) to subdermal sites.Type: ApplicationFiled: October 28, 2019Publication date: April 23, 2020Inventors: Jeffry Twidwell, Joel Buckley, Harold Hoium
-
Patent number: 10471131Abstract: The invention provides topical compositions and methods for using the compositions. The compositions can be used for the treatment of fibrotic or connective tissue disorders involving scarring, sub-dermal plaque accumulations, or fibrosis of muscle tissue. The disorders can be painlessly treated by the topical application of a composition described herein. One or more calcium channel blocker agents can serve as an active ingredient of the compositions, optionally in combination with, for example, one or more of emu oil and superoxide dismutase. The composition can further include pharmaceutically acceptable carriers that can facilitate the non-invasive transdermal delivery of the active(s) to subdermal sites.Type: GrantFiled: December 28, 2015Date of Patent: November 12, 2019Assignee: Hybrid Medical, LLCInventors: Jeff Twidwell, Joel Buckley, Harold Hoium
-
Publication number: 20160129091Abstract: The invention provides topical compositions and methods for using the compositions. The compositions can be used for the treatment of fibrotic or connective tissue disorders involving scarring, sub-dermal plaque accumulations, or fibrosis of muscle tissue. The disorders can be painlessly treated by the topical application of a composition described herein. One or more calcium channel blocker agents can serve as an active ingredient of the compositions, optionally in combination with, for example, one or more of emu oil and superoxide dismutase. The composition can further include pharmaceutically acceptable carriers that can facilitate the non-invasive transdermal delivery of the active(s) to subdermal sites.Type: ApplicationFiled: December 28, 2015Publication date: May 12, 2016Inventors: Jeff Twidwell, Joel Buckley, Harold Hoium
-
Patent number: 9333242Abstract: The invention provides topical compositions and methods for using the compositions. The compositions can be used for the treatment of fibrotic or connective tissue disorders involving scarring, sub-dermal plaque accumulations, or fibrosis of muscle tissue. The disorders can be painlessly treated by the topical application of a composition described herein. One or more calcium channel blocker agents can serve as an active ingredient of the compositions, optionally in combination with, for example, one or more of emu oil and superoxide dismutase. The composition can further include pharmaceutically acceptable carriers that can facilitate the non-invasive transdermal delivery of the active(s) to subdermal sites.Type: GrantFiled: January 22, 2013Date of Patent: May 10, 2016Assignee: Hybrid Medical, LLCInventors: Jeff Twidwell, Joel Buckley, Harold Hoium
-
Publication number: 20160106816Abstract: The invention provides topical compositions and methods for using the compositions. The compositions can be used for the treatment of fibrotic or connective tissue disorders involving scarring, sub-dermal plaque accumulations, or fibrosis of muscle tissue. The disorders can be painlessly treated by the topical application of a composition described herein. One or more calcium channel blocker agents can serve as an active ingredient of the compositions, optionally in combination with, for example, one or more of emu oil and superoxide dismutase. The composition can further include pharmaceutically acceptable carriers that can facilitate the non-invasive transdermal delivery of the active(s) to subdermal sites.Type: ApplicationFiled: December 21, 2015Publication date: April 21, 2016Inventors: Jeff Twidwell, Joel Buckley, Harold Hoium
-
Patent number: 9238059Abstract: The invention provides topical compositions and methods for using the compositions. The compositions can be used for the treatment of fibrotic or connective tissue disorders involving scarring, sub-dermal plaque accumulations, or fibrosis of muscle tissue. The disorders can be painlessly treated by the topical application of a composition described herein. One or more calcium channel blocker agents can serve as an active ingredient of the compositions, optionally in combination with, for example, one or more of emu oil and superoxide dismutase. The composition can further include pharmaceutically acceptable carriers that can facilitate the non-invasive transdermal delivery of the active(s) to subdermal sites.Type: GrantFiled: January 30, 2015Date of Patent: January 19, 2016Assignee: Hybrid Medical, LLCInventors: Jeff Twidwell, Joel Buckley, Harold Hoium
-
Publication number: 20150150949Abstract: The invention provides topical compositions and methods for using the compositions. The compositions can be used for the treatment of fibrotic or connective tissue disorders involving scarring, sub-dermal plaque accumulations, or fibrosis of muscle tissue. The disorders can be painlessly treated by the topical application of a composition described herein. One or more calcium channel blocker agents can serve as an active ingredient of the compositions, optionally in combination with, for example, one or more of emu oil and superoxide dismutase. The composition can further include pharmaceutically acceptable carriers that can facilitate the non-invasive transdermal delivery of the active(s) to subdermal sites.Type: ApplicationFiled: January 30, 2015Publication date: June 4, 2015Inventors: Jeff Twidwell, Joel Buckley, Harold Hoium
-
Patent number: 8416817Abstract: A modelocked fiber laser is designed to have strong pulse-shaping based on spectral filtering of a highly-chirped pulse in the laser cavity. The laser generates femtosecond pulses without a dispersive delay line or anomalous dispersion in the cavity.Type: GrantFiled: September 18, 2007Date of Patent: April 9, 2013Assignee: Cornell UniversityInventors: Chin Yu Chong, Joel Buckley, Frank Wise
-
Publication number: 20130020367Abstract: A display device for a golf ball marker includes a mechanism for temporary attaching the display device or insert at a visible position on a person, and a holding portion (structure) attached to the mechanism. The ball marker holding portion also includes a magnetic force portion, and a gripping portion adapted to apply a holding force on a ball marker. The magnetic force portion includes a magnet; and an element including a recess for receiving the magnet. A wristband can operate as the display device for the ball marker, which is removable from the temporary attachment to the wristband. The attachment can hold the marker in place while the person moves and plays golf, e.g., swings a golf club. The wristband can be a silicone wristband.Type: ApplicationFiled: July 20, 2012Publication date: January 24, 2013Inventor: Joel BUCKLEY
-
Publication number: 20110290683Abstract: A golf bag banner includes a flexible body movable between at least a first position and a second position and a connector mechanism to secure the flexible body to a movable leg of a golf bag. A fixture is provided to hold the banner along the length of leg. A golf bag is essentially a container to receive golf clubs therein. A stand mechanism can be connected to the container to provide a bag stand position and a retracted position. The bag banner can be fixed to the stand mechanism, e.g., connected between two legs of the stand mechanism. The bag banner can include a flexible body, e.g., a fabric, movable between at least the stand position and the retracted position and a connector system to secure the flexible body to the two legs. The bag banner can incorporate logos and other insignia that a manufacturer or golfer would like to display with his/her golf bag.Type: ApplicationFiled: May 26, 2011Publication date: December 1, 2011Inventors: Randal High, Joel Buckley
-
Publication number: 20100220751Abstract: A modelocked fiber laser is designed to have strong pulse-shaping based on spectral filtering of a highly-chirped pulse in the laser cavity. The laser generates femtosecond pulses without a dispersive delay line or anomalous dispersion in the cavity.Type: ApplicationFiled: September 18, 2007Publication date: September 2, 2010Inventors: Chin Yu Chong, Joel Buckley, Frank Wise
-
Patent number: D687632Type: GrantFiled: February 11, 2011Date of Patent: August 13, 2013Assignee: Drenaline Products, LLCInventors: Randal High, Joel Buckley
-
Patent number: D694662Type: GrantFiled: November 9, 2011Date of Patent: December 3, 2013Inventor: Joel Buckley